Bacterial adhesion on PEG modified polyurethane surfaces

Biomaterials
K D ParkK S Choi

Abstract

Polyurethane surface was modified with poly(ethylene glycol) (mol. wt. 1000, PEG1k) carrying terminal hydroxyl, amino and sulfonate groups, poly(ethylene glucol) (mol. wt. 3350, PEG3.4k) and PEG3.4k-Heparin, respectively. These surfaces were investigated for bacterial adhesion using S. epidermidis and E. coli in tryptic soya broth (TSB), brain heart infusion (BHI), and human plasma. All PEG modified surfaces reduced bacterial adhesion significantly and the adhesion level differs depending on surfaces as well as media. In the case of PEG1k surfaces, no reduction of S. epidermidis adhesion was demonstrated in TSB media, regardless of terminal functional groups of PEG1k. However, adhesion in plasma was reduced to the different degree, depending on terminal groups of PEG1k (least adhesion on sulfonated PEG surface). Relatively longer PEG surface (PEG3.4k) and PEG3.4k-heparin surface minimized bacterial adhesion in both media. In the case of E. coli adhesion, significant reduction in adherent bacteria was observed on all PEG1k, PEG3.4k, and PEG-heparin surfaces in both media compared to controls. In contrast, no reduction in bacterial adhesion was demonstrated on poly(propylene glycol) (PPG1k) grafted PU surface as compared to contr...Continue Reading

Citations

Mar 21, 2001·Biotechnology and Bioengineering·J C TillerA M Klibanov
May 10, 2002·Journal of Biomedical Materials Research·S LakshmiA Jayakrishnan
Sep 25, 2004·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Ho-Wook Jun, Jennifer L West
Mar 6, 2007·Journal of Materials Science. Materials in Medicine·Si-Nae ParkHwal Suh
Apr 2, 2003·Advances in Colloid and Interface Science·E P K CurrieM A Cohen Stuart
Aug 6, 1999·Biochimica Et Biophysica Acta·K M Stuhlmeier, Y Lin
Jan 25, 2003·Diagnostic Microbiology and Infectious Disease·Marta MonzónBeatriz Amorena
Aug 1, 2000·Colloids and Surfaces. B, Biointerfaces·H J LeeY H Kim
Nov 3, 2011·ACS Applied Materials & Interfaces·Tadas S SileikaPhillip B Messersmith
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·J C TillerA M Klibanov
Aug 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Alexander K EpsteinJoanna Aizenberg
Mar 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ronn S FriedlanderJoanna Aizenberg
Dec 5, 2002·Journal of Biomaterials Science. Polymer Edition·Hee Jung LeeYoung Ha Kim
May 16, 2003·Journal of Biomaterials Science. Polymer Edition·Hans J KaperWillem Norde
Feb 12, 2004·Journal of Biomaterials Science. Polymer Edition·J YuanS C Lin
Oct 6, 2004·Journal of Biomaterials Science. Polymer Edition·Li-Fen WangJen-Feng Kuo
Sep 3, 2009·Journal of Biomaterials Science. Polymer Edition·G KimM Ree
Mar 16, 2012·International Journal of Nanomedicine·Jonathan LelloucheEhud Banin
Aug 21, 2012·International Journal of Nanomedicine·Mary C MachadoThomas J Webster
Oct 9, 2014·Biomacromolecules·Jian YangGuillermo A Ameer
Apr 5, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·David Perera-CostaVirginia Vadillo-Rodríguez
Mar 25, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Günther GratzlMaximilian Lackner
Mar 5, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rayk Hassert, Annette G Beck-Sickinger
Jul 10, 2012·Colloids and Surfaces. B, Biointerfaces·Yifeng WangYanfei Xiong
Aug 9, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jung Seok LeeJan Feijen
Jul 21, 2015·ACS Applied Materials & Interfaces·Chen XuXin-Song Li
Nov 29, 2015·Colloids and Surfaces. B, Biointerfaces·Jessie PeyreClaire-Marie Pradier
Oct 30, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Lydie SeonFouzia Boulmedais
Feb 21, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·He XuMegan E Núñez
Dec 17, 2015·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Li-Chong Xu, Christopher A Siedlecki
Mar 1, 2005·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Astrid RoosjenHenk J Busscher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.